Publication | Closed Access

Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species

Pharmacological StudyNqo1 Bioactivatable MoleculeDomestic Felid SpeciesPharmacologyPharmacotherapyAnti-cancer AgentDrug DevelopmentMedicinePharmacokineticsDrug DiscoveryDrug Resistance